147 related articles for article (PubMed ID: 18086251)
21. Radioimmunometric assay of B-type natriuretic peptide (BNP) in heart transplantation: correlation between BNP determinations and biopsy grading of rejection.
Hervás I; Almenar L; Pérez-Pastor JL; Chirivella M; Osa A; Martínez-Dolz L; Bello P; Martí JF; Arnau MA; Vera F; Rueda J; Palencia M; Mateo A
Nucl Med Commun; 2003 Aug; 24(8):925-31. PubMed ID: 12869826
[TBL] [Abstract][Full Text] [Related]
22. B-type natriuretic peptide levels late after transplant predict graft survival in pediatric heart transplant patients.
Rossano JW; Denfield SW; Kim JJ; Price JF; Jefferies JL; Decker JA; Dreyer WJ
J Heart Lung Transplant; 2010 Mar; 29(3):385-6. PubMed ID: 19782608
[No Abstract] [Full Text] [Related]
23. NTproBNP as a marker of rejection in pediatric heart transplant recipients.
Knecht KR; Alexander ML; Swearingen CJ; Frazier EA
Pediatr Transplant; 2012 Jun; 16(4):335-9. PubMed ID: 22429516
[TBL] [Abstract][Full Text] [Related]
24. Impact of systemic hypertension on the diagnostic performance of B-type natriuretic peptide in patients with acute dyspnea.
Pahle AS; Sørli D; Omland T; Knudsen CW; Westheim A; Wu AH; Steg PG; McCord J; Nowak RM; Hollander JE; Storrow AB; Abraham WT; McCullough PA; Maisel A
Am J Cardiol; 2009 Oct; 104(7):966-71. PubMed ID: 19766765
[TBL] [Abstract][Full Text] [Related]
25. Is brain natriuretic peptide clinically useful after cardiac transplantation?
Shaw SM; Williams SG
J Heart Lung Transplant; 2006 Dec; 25(12):1396-401. PubMed ID: 17178331
[TBL] [Abstract][Full Text] [Related]
26. Calprotectin: a novel noninvasive marker for intestinal allograft monitoring.
Sudan D; Vargas L; Sun Y; Bok L; Dijkstra G; Langnas A
Ann Surg; 2007 Aug; 246(2):311-5. PubMed ID: 17667511
[TBL] [Abstract][Full Text] [Related]
27. B-type natriuretic peptide trends after pediatric heart transplantation.
Sparks JD; Boston U; Eghtesady P; Canter CE
Pediatr Transplant; 2014 Aug; 18(5):477-84. PubMed ID: 24922348
[TBL] [Abstract][Full Text] [Related]
28. B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure.
Valle R; Aspromonte N; Giovinazzo P; Carbonieri E; Chiatto M; di Tano G; Feola M; Milli M; Fontebasso A; Barro S; Bardellotto S; Milani L
J Card Fail; 2008 Apr; 14(3):219-24. PubMed ID: 18381185
[TBL] [Abstract][Full Text] [Related]
29. Cause of death in pediatric and infant heart transplant recipients: review of a 20-year, single-institution cohort.
Zuppan CW; Wells LM; Kerstetter JC; Johnston JK; Bailey LL; Chinnock RE
J Heart Lung Transplant; 2009 Jun; 28(6):579-84. PubMed ID: 19481018
[TBL] [Abstract][Full Text] [Related]
30. B-type natriuretic peptide assessment in the diagnosis of rejection after pediatric heart transplant.
Sylos Cd; Azeka E; Kajita L; Benvenutti L; Strunz CC; Branco KC; Riso AA; Tanamati C; Jatene M; Barbero-Marcial M
Arq Bras Cardiol; 2009 Mar; 92(3):215-26. PubMed ID: 19390711
[TBL] [Abstract][Full Text] [Related]
31. Baseline and 6-month B-type natriuretic peptide changes are independent predictors of events in patients with advanced heart failure awaiting cardiac transplantation.
Campana C; Pasotti M; Klersy C; Alessandrino G; Albertini R; Magrini G; Ghio S; Tavazzi L
J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):671-6. PubMed ID: 19444135
[TBL] [Abstract][Full Text] [Related]
32. Predictive role of pretransplant serum CXCL10 for cardiac acute rejection.
Crescioli C; Buonamano A; Scolletta S; Sottili M; Francalanci M; Giomarelli P; Biagioli B; Lisi G; Pradella F; Serio M; Romagnani P; Maccherini M
Transplantation; 2009 Jan; 87(2):249-55. PubMed ID: 19155980
[TBL] [Abstract][Full Text] [Related]
33. B-type natriuretic peptide in the emergency diagnosis of critical heart disease in children.
Maher KO; Reed H; Cuadrado A; Simsic J; Mahle WT; Deguzman M; Leong T; Bandyopadhyay S
Pediatrics; 2008 Jun; 121(6):e1484-8. PubMed ID: 18519452
[TBL] [Abstract][Full Text] [Related]
34. Determinants of brain natriuretic peptide gene expression and secretion in acute cardiac allograft rejection.
de Bold AJ
Curr Opin Cardiol; 2007 Mar; 22(2):146-50. PubMed ID: 17284995
[TBL] [Abstract][Full Text] [Related]
35. Prognostic relationship between two serial determinations of B-type natriuretic peptide and medium-long-term events in heart transplantation.
Martínez-Dolz L; Almenar L; Hervás I; Moro J; Agüero J; Sánchez-Lázaro I; Mateo A; Salvador A
J Heart Lung Transplant; 2008 Jul; 27(7):735-40. PubMed ID: 18582802
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic utility of B-type natriuretic peptide in critically ill patients with pulmonary edema: a prospective cohort study.
Levitt JE; Vinayak AG; Gehlbach BK; Pohlman A; Van Cleve W; Hall JB; Kress JP
Crit Care; 2008; 12(1):R3. PubMed ID: 18194554
[TBL] [Abstract][Full Text] [Related]
37. Plasma B-type natriuretic peptide for early diagnosis of allograft rejection after renal transplantation.
Sun TW; Zhang SY; Wang LX
Med Hypotheses; 2008; 70(6):1160-2. PubMed ID: 18191909
[TBL] [Abstract][Full Text] [Related]
38. [Screening for asymptomatic left ventricular systolic dysfunction in high-risk patients. Preliminary experience with a program based on the use of ECG and natriuretic peptide].
Tarantini L; Cioffi G; Di Lenarda A; Valle R; Pulignano G; Del Sindaco D; Frigo G; Soravia G; Tessier R; Catania G
G Ital Cardiol (Rome); 2008 Dec; 9(12):835-43. PubMed ID: 19119693
[TBL] [Abstract][Full Text] [Related]
39. Clinical relevance of measurement of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in pediatric cardiology.
Cantinotti M; Clerico A; Murzi M; Vittorini S; Emdin M
Clin Chim Acta; 2008 Apr; 390(1-2):12-22. PubMed ID: 18230356
[TBL] [Abstract][Full Text] [Related]
40. B-type natriuretic peptide as a predictor of postoperative heart failure after aortic valve replacement.
Nozohoor S; Nilsson J; Lührs C; Roijer A; Algotsson L; Sjögren J
J Cardiothorac Vasc Anesth; 2009 Apr; 23(2):161-5. PubMed ID: 19167912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]